The CRISPR-Cas9 technology is one of the most significant discoveries in genetics, allowing for highly precise gene editing and modification. It offers unprecedented possibilities for treating genetic diseases at the level of stem cells or embryos. This technology opens new horizons for curing conditions such as sickle cell anemia, cystic fibrosis, and certain types of cancer by directly correcting the genetic mutation causing the disease.<br /><br />However, alongside this remarkable progress come profound concerns regarding environmental, ethical, and social safety—particularly when these genetic modifications can be passed down to future generations. Excessive or unregulated use of this technology beyond medically supervised applications could lead to unpredictable consequences for the human genome, the food chain, or biological diversity.<br /><br />Therefore, the implementation of CRISPR must take place within a strict regulatory framework that includes thorough environmental assessments, clear public consent, and integration with healthcare and academic institutions. Despite the challenges, responsible and sustainable use of CRISPR can reduce the need for long-term treatments, ease the burden on healthcare systems, and lower the consumption of medications and resources—supporting sustainable healthcare.<br /><br />Moreover, CRISPR technology can be safely applied to enhance crop resistance to diseases, contributing to food security and reducing reliance on harmful pesticides. Gene editing represents a turning point in both medicine and the environment, and must be accompanied by deep scientific and ethical awareness to ensure continued benefit without harm to living organisms or the planet.<br /><br />Al-Mustaqbal University is the first university in Iraq.